Handwashing and horizontal spread of viruses.

Comparative in vivo efficiencies of hand-washing agents against hepatitis A virus (HM-175) and poliovirus type 1 (Sabin). Appl Environ Microbiol (1993) 0.90

Handwashing and horizontal spread of viruses. Lancet (1989) 0.75

Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology (1979) 3.80

Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. Virology (1969) 2.91

Structure of simian virus 40. II. Symmetry and components of the virus particle. Virology (1967) 2.62

Structure of simian virus 40. I. Purification and physical characterization of the virus particle. Virology (1967) 2.21

Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyl-4-chlorobenzoylhydrazine. J Exp Med (1969) 1.56

Selective inhibiton of uncoating of echovirus 12 by rhodanine. A study on early virus-cell interactions. Virology (1977) 1.39

Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res (1987) 1.28

Antiviral activity of an alcoholic hand disinfectant. Comparison of the in vitro suspension test with in vivo experiments on hands, and on individual fingertips. Antiviral Res (1983) 1.28

Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology (1979) 1.24

In vivo genetic variability of the HIV-1 vif gene. Virology (1994) 1.18

In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells. Biotechniques (1990) 1.14

Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J Med Virol (1994) 1.08

Molecular cloning and sequence determination of the complete genome of the virulent echovirus 9 strain barty. Virus Genes (1996) 1.06

Integrin alpha(v)beta3 (vitronectin receptor) is a candidate receptor for the virulent echovirus 9 strain Barty. J Gen Virol (1999) 1.04

Rhodanine: a selective inhibitor of the multiplication of echovirus 12. Science (1970) 1.03

Cell attachment and mouse virulence of echovirus 9 correlate with an RGD motif in the capsid protein VP1. Virology (1997) 1.01

Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness. Lancet (1988) 0.99

Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda. J Gen Virol (1997) 0.99

Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology (1983) 0.99

Comparison of two commercially available anti-HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III-ELISA. J Med Virol (1987) 0.97

Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids. J Virol (1995) 0.96

Antiviral chemotherapy. Annu Rev Pharmacol (1966) 0.96

[Guidelines for the testing and evaluation of skin disinfectants]. Zentralbl Hyg Umweltmed (1991) 0.95

Complete nucleotide sequence and biological properties of an infectious clone of prototype echovirus 9. Virus Res (1995) 0.93

Quantitative measurement of uptake of alloantibody on mouse lymphocytes. Eur J Biochem (1970) 0.92

HPLC is an effective and fast method for analysis of viral proteins: a study of encephalomyocarditis virus mutants differing in pathogenicity. J Gen Virol (1993) 0.91

Biochemistry and pathogenicity of echovirus 9. I. Characterization of the virus particles of strains Barty and Hill. Virology (1982) 0.90

Experimental reovirus myocarditis in newborn mice. Electron microscopic observations. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.89

The complete nucleotide sequence and construction of an infectious cDNA clone of a highly virulent encephalomyocarditis virus. Virology (1994) 0.89

An experimental study on the epidemiology of enteroviruses: water and soap washing of poliovirus 1--contaminated hands, its effectiveness and kinetics. Med Microbiol Immunol (1985) 0.88

A rapid and reliable assay for testing acyclovir sensitivity of clinical herpes simplex virus isolates independent of virus dose and reading time. Antiviral Res (1994) 0.87

Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro. J Gen Virol (1982) 0.87

Analysis of sequence and pathogenic properties of two variants of encephalomyocarditis virus differing in a single amino acid in VP1. Virus Res (1996) 0.86

Chemical approaches to selective inhibition of viral multiplication. Calif Med (1965) 0.86

The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J Gen Virol (2000) 0.86

Quantitation of human cytomegalovirus genomes in the brain of AIDS patients. J Med Virol (1995) 0.85

A single-cell study of chemical inhibition of enterovirus multiplication. Virology (1965) 0.85

Encephalomyocarditis virus and diabetes mellitus: studies on virus mutants in susceptible and non-susceptible mice. J Gen Virol (1985) 0.85

Echovirus 9 strain barty non-structural protein 2C has NTPase activity. Virus Res (1999) 0.85

Age dependence of paralysis induced by echovirus type 9 in infant mice. J Infect Dis (1983) 0.84

Peripheral facial palsy and infections- findings and problems. Med Microbiol Immunol (1982) 0.83

[Directives for the testing and evaluation of chemical disinfection methods--1st part (1.1.1981). I. In vitro tests. II. Tests under medical practice conditions. 1. Hygienic hand disinfection. 2. Surgical hand disinfection]. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 0.83

Selective inhibition of human neutrophil chemotaxis by ECHO-virus, type 9. Klin Wochenschr (1981) 0.83

[Quantitative determination of rubella virus antibodies in capillary blood. A simple, reliable and economic method (author's transl)]. MMW Munch Med Wochenschr (1980) 0.83

Mutants of the simian virus 40 which differ in cell-transforming activity. Nature (1967) 0.83

The poly(C) region affects progression of encephalomyocarditis virus infection in Langerhans' islets but not in the myocardium. J Virol (1997) 0.82

Successful treatment of enterovirus-infected mice by 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine. J Exp Med (1976) 0.82

Reproducibility of HIV antigen test. Lancet (1988) 0.81

SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity. Antiviral Res (1995) 0.81

Comparison of four different methods for detection of rubella IgM antibodies. Med Microbiol Immunol (1983) 0.81

Detection of HIV in human vitreous. Int Ophthalmol (1993) 0.81

Rhodanine resistance and dependence of echovirus 12: a possible consequence of capsid flexibility. J Virol (1997) 0.81

Echovirus-9 protein 2C binds single-stranded RNA unspecifically. J Gen Virol (2000) 0.80

Dependence of echovirus 9 on the enterovirus RNA replication inhibitor 2-(alpha-Hydroxybenzyl)-benzimidazole maps to nonstructural protein 2C. J Virol (1999) 0.80

Structure and replication of echovirus type 12. 1. Analysis of the polypeptides and RNA of echovirus 12 particles. Eur J Biochem (1978) 0.80

[An epidemic in a maternity unit caused by an echo virus 11 variant (author's transl)]. MMW Munch Med Wochenschr (1980) 0.80

[Isoprinosine: evaluation of its virus inhibiting action in vivo and in vitro]. Dtsch Med Wochenschr (1972) 0.80

Synthesis and activity of RNA polymerase of a temperature sensitive poliovirus mutant at an elevated temperature. Nature (1968) 0.80

Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies. J Med Virol (1998) 0.79

Cytoplasmic localization of the uncoating of picornaviruses. Virology (1979) 0.79

Fatty acid-depleted albumin induces the formation of echovirus A particles. J Virol (2000) 0.79

A factor capable of enhancing interferon synthesis. Virology (1969) 0.79

Ultrastructural degenerative changes of age-dependent ECHO 9 virus-induced polymyositis in infant mice. Virchows Arch B Cell Pathol Incl Mol Pathol (1981) 0.79

Structure and replication of echovirus type 12. 2. Viral polypeptides synthesized in the infected cell. Eur J Biochem (1978) 0.79

Determinants of pathogenicity of echovirus 9 in men: significance of a functional RGD-motif. Zentralbl Bakteriol (1999) 0.78

Structural requirements of selective inhibition of enteroviruses by 2-(alpha-hydroxybenzyl)-benzimidazole and related compounds. Nature (1969) 0.78

Isolation and characterization of temperature-sensitive mutants of echovirus 12. Virology (1979) 0.78

Persistence of Coxsackie B virus-specific IgM. Lancet (1986) 0.78

Epidemiology of an outbreak in a maternity unit of infections with an antigenic variant of Echovirus 11. J Med Virol (1982) 0.78

[Lamivudine resistance impedes hepatitis B therapy]. Fortschr Med (1997) 0.78

[Studies on optimising rubella virus haemagglutination-inhibitor tests]. Dtsch Med Wochenschr (1976) 0.78

Echo 9 virus-induced order-disorder transition of chemotactic response of human polymorphonuclear leucocytes: phenomenology and molecular biology. Blood Cells (1984) 0.77

Cardiomyocytes of adult mice in long-term culture. Naturwissenschaften (1993) 0.77

In vivo efficacy of SDZ 35-682, a new picornavirus capsid-binding agent. Antiviral Res (1995) 0.77

Effect of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine on the uncoating of echovirus 12. Nature (1970) 0.77

Detection of DNA-protein binding in western blots by phosphorus-labeled and biotinylated DNA probes. Biotechniques (1988) 0.77

Quantification of HIV-1 proviral DNA and analysis of genomic diversity by polymerase chain reaction and temperature gradient gel electrophoresis. J Virol Methods (1996) 0.76

Use of biotinylated DNA probes in screening cells obtained from cervical swabs for human papillomavirus DNA sequences. Acta Cytol (1987) 0.76

[Clinical relevance of nucleic acid detection of human papillomaviruses (HPV) in cells from smears of the cervix uteri]. Geburtshilfe Frauenheilkd (1989) 0.76

Provocation paralysis. Lancet (1993) 0.75

[Moroxydine]. Dtsch Med Wochenschr (1980) 0.75

[Value of the HIV-p24 antigen test in blood banks]. Med Klin (Munich) (1994) 0.75

Inhibition of enterovirus cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole. J Bacteriol (1966) 0.75

Poliomyelitis in Oman. Lancet (1991) 0.75

Difficulties in polio eradication. Lancet (2001) 0.75

Human herpesvirus 6 and the Henle-Koch postulates. Lancet (1988) 0.75

[Detection of viral nucleic acid sequences in paraffin and cryostat sections of clinical study samples using in situ hybridization]. Acta Histochem Suppl (1989) 0.75

[The technic of "in situ hybridization"]. Fortschr Med (1988) 0.75

[HIV infection. The risk of AIDS caused by transfusion is slight, but can be further decreased]. Fortschr Med (1988) 0.75

Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations. Infection (1989) 0.75

Comparison of the detection of cervical human papillomavirus infection by filter DNA hybridization of cytologic specimens and by in situ DNA hybridization of tissues. Acta Cytol (1990) 0.75

[Viruses of the herpes group]. Fortschr Med (1989) 0.75

Neutral red-labeled influenza virus loses photosensitivity during absorption to host cells but not to erythrocytes. Arch Virol (1989) 0.75

Letters to the Editor. Science (1964) 0.75

On the structure of the epidemic spread of AIDS: the influence of an infectious coagent. Zentralbl Bakteriol (1990) 0.75

Chronic herpes simplex virus and varicella zoster virus infection. J Virol Methods (1988) 0.75

[Experimental and bacterial conditioned Coxsackie B virus-induced pancreatitis]. Verh Dtsch Ges Pathol (1987) 0.75

[Rotavirus infections]. Z Gastroenterol Verh (1990) 0.75

[Letter: Opinion on the influenza-protective vaccination using Mutagrip]. Dtsch Med Wochenschr (1974) 0.75

Biochemistry and pathogenicity of echovirus 9. III. Thermosensitive mutants of echovirus 9, strain Barty, with reduced pathogenicity for newborn mice. Med Microbiol Immunol (1988) 0.75